PMVP Insider Trading (PMV Pharmaceuticals)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $17,100,000.00
Insider Selling (Last 12 Months): $10,357,746.76
PMV Pharmaceuticals Insider Trading History Chart
PMV Pharmaceuticals Share Price & Price History
$35.00
As of 05/7/2021 01:00 AM ET
#1 Stock for the $3 TRILLION EV Revolution
From IPM-CJB | Ad
Forbes calls it, “The battery that could change the world.” $3 stock holds key patents. Investing Legend Matt McCall reveals, in his FREE video, the small company behind this brand new super battery that will drive the $3 Trillion electric car revolution.
Click HERE.
PMV Pharmaceuticals Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/5/2021 | Thilo Schroeder | Director | Sell | 600 | $35.64 | $21,384.00 | |  |
| 5/3/2021 | Winston Kung | CFO | Sell | 4,500 | $33.75 | $151,875.00 | 6,100 | |
| 4/12/2021 | Thilo Schroeder | Director | Sell | 3,903 | $31.41 | $122,593.23 | | |
| 4/8/2021 | Thilo Schroeder | Director | Sell | 136,436 | $34.31 | $4,681,119.16 | | |
| 4/7/2021 | Leila Alland | Insider | Sell | 4,000 | $33.86 | $135,440.00 | 4,000 | |
| 4/5/2021 | Thilo Schroeder | Director | Sell | 48,193 | $33.81 | $1,629,405.33 | | |
| 3/31/2021 | Thilo Schroeder | Director | Sell | 33,626 | $32.52 | $1,093,517.52 | | |
| 3/29/2021 | Thilo Schroeder | Director | Sell | 2,174 | $32.15 | $69,894.10 | | |
| 3/26/2021 | Thilo Schroeder | Director | Sell | 35,268 | $33.44 | $1,179,361.92 | | |
| 3/24/2021 | Thilo Schroeder | Director | Sell | 34,881 | $36.50 | $1,273,156.50 | | |
| 9/29/2020 | Ra Capital Management, L.P. | Major Shareholder | Buy | 950,000 | $18.00 | $17,100,000.00 | | |
SEC Filings (Institutional Ownership Changes) for PMV Pharmaceuticals (NASDAQ:PMVP)
69.72% of PMV Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.
Institutional Buying and Selling by Quarter
PMV Pharmaceuticals Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 5/7/2021 | BlackRock Inc. | 1,425,873 | $46.90M | 0.0% | +6.0% | 3.173% |  |
| 5/6/2021 | Alliancebernstein L.P. | 9,800 | $0.32M | 0.0% | +5.4% | 0.022% | |
| 5/5/2021 | Hamilton Lane Advisors LLC | 6,154 | $0.20M | 0.1% | N/A | 0.014% | |
| 5/4/2021 | Victory Capital Management Inc. | 799,001 | $26.28M | 0.0% | +21.9% | 1.778% | |
| 4/29/2021 | Hershey Trust Co. | 7,692 | $0.25M | 0.0% | N/A | 0.017% | |
| 4/21/2021 | Personal CFO Solutions LLC | 854,684 | $28.11M | 6.1% | N/A | 1.909% | |
| 4/15/2021 | Interwest Venture Management Co. | 5,469,911 | $179.91M | 47.3% | -15.5% | 12.214% | |
| 3/1/2021 | UBS Asset Management Americas Inc. | 194,825 | $11.98M | 0.0% | -44.3% | 0.435% | |
| 2/23/2021 | Principal Financial Group Inc. | 196,455 | $12.08M | 0.0% | -2.2% | 0.439% | |
| 2/19/2021 | JPMorgan Chase & Co. | 37,099 | $2.28M | 0.0% | +271.0% | 0.083% | |
| 2/16/2021 | HighVista Strategies LLC | 22,654 | $1.39M | 0.9% | N/A | 0.051% | |
| 2/16/2021 | Nuveen Asset Management LLC | 50,017 | $3.08M | 0.0% | N/A | 0.112% | |
| 2/16/2021 | Viking Global Investors LP | 2,364,062 | $145.41M | 0.4% | -10.5% | 5.280% | |
| 2/16/2021 | Jefferies Group LLC | 10,000 | $0.62M | 0.0% | N/A | 0.022% | |
| 2/16/2021 | Avoro Capital Advisors LLC | 2,350,267 | $130.54M | 2.2% | +27.0% | 5.249% | |
| 2/16/2021 | Acuta Capital Partners LLC | 15,000 | $0.92M | 0.3% | N/A | 0.034% | |
| 2/16/2021 | Charles Schwab Investment Management Inc. | 83,164 | $5.12M | 0.0% | N/A | 0.186% | |
| 2/13/2021 | American International Group Inc. | 7,941 | $0.49M | 0.0% | N/A | 0.018% | |
| 2/12/2021 | The Manufacturers Life Insurance Company | 7,850 | $0.48M | 0.0% | N/A | 0.018% | |
| 2/12/2021 | Credit Suisse AG | 4,027 | $0.25M | 0.0% | N/A | 0.009% | |
| 2/12/2021 | M&T Bank Corp | 4,521 | $0.28M | 0.0% | N/A | 0.010% | |
| 2/11/2021 | Northern Trust Corp | 156,278 | $9.61M | 0.0% | +878.1% | 0.349% | |
| 2/11/2021 | Citigroup Inc. | 2,575 | $0.16M | 0.0% | N/A | 0.006% | |
| 2/11/2021 | Asymmetry Capital Management L.P. | 96,595 | $5.94M | 2.7% | +288.1% | 0.216% | |
| 2/10/2021 | Rhumbline Advisers | 13,928 | $0.86M | 0.0% | N/A | 0.031% | |
| 2/9/2021 | Wells Fargo & Company MN | 7,083 | $0.44M | 0.0% | N/A | 0.016% | |
| 2/9/2021 | Bank of New York Mellon Corp | 41,294 | $2.54M | 0.0% | N/A | 0.092% | |
| 2/8/2021 | Alliancebernstein L.P. | 9,300 | $0.57M | 0.0% | N/A | 0.021% | |
| 2/8/2021 | Principal Financial Group Inc. | 196,455 | $12.08M | 0.0% | -2.2% | 0.439% | |
| 2/8/2021 | New York State Common Retirement Fund | 10,600 | $0.65M | 0.0% | N/A | 0.024% | |
| 2/6/2021 | Jennison Associates LLC | 148,594 | $9.14M | 0.0% | -0.9% | 0.332% | |
| 2/5/2021 | BlackRock Inc. | 1,345,015 | $82.73M | 0.0% | +148.1% | 3.004% | |
| 2/1/2021 | Victory Capital Management Inc. | 655,709 | $40.33M | 0.0% | +17.5% | 1.464% | |
| 1/25/2021 | Strs Ohio | 3,300 | $0.20M | 0.0% | N/A | 0.007% | |
| 12/30/2020 | Deerfield Management Company L.P. Series C | 50,000 | $1.78M | 0.0% | N/A | 0.112% | |
| 11/17/2020 | Jane Street Group LLC | 31,349 | $1.11M | 0.0% | N/A | 0.073% | |
| 11/17/2020 | Logos Global Management LP | 150,000 | $5.33M | 0.7% | N/A | 0.349% | |
| 11/17/2020 | Boxer Capital LLC | 2,268,236 | $80.52M | 2.8% | N/A | 5.275% | |
| 11/16/2020 | Point72 Hong Kong Ltd | 6,291 | $0.22M | 0.0% | N/A | 0.015% | |
| 11/16/2020 | OLD Mission Capital LLC | 51,700 | $1.84M | 0.1% | N/A | 0.115% | |
| 11/16/2020 | Squarepoint Ops LLC | 22,156 | $0.79M | 0.0% | N/A | 0.052% | |
| 11/16/2020 | Perceptive Advisors LLC | 605,556 | $21.50M | 0.3% | N/A | 1.408% | |
| 11/16/2020 | ArrowMark Colorado Holdings LLC | 400,000 | $14.20M | 0.1% | N/A | 0.930% | |
| 11/16/2020 | EcoR1 Capital LLC | 50,000 | $1.78M | 0.1% | N/A | 0.116% | |
| 11/16/2020 | Alkeon Capital Management LLC | 475,000 | $16.86M | 0.0% | N/A | 1.105% | |
| 11/13/2020 | Morgan Stanley | 6,900 | $0.25M | 0.0% | N/A | 0.016% | |
| 11/13/2020 | UBS Asset Management Americas Inc. | 350,000 | $12.43M | 0.0% | N/A | 0.814% | |
| 11/12/2020 | JPMorgan Chase & Co. | 10,000 | $0.38M | 0.0% | N/A | 0.023% | |
| 11/12/2020 | Federated Hermes Inc. | 250,000 | $8.88M | 0.0% | N/A | 0.581% | |
| 11/9/2020 | Victory Capital Management Inc. | 557,843 | $19.80M | 0.0% | N/A | 1.297% | |
| 11/6/2020 | BlackRock Inc. | 542,038 | $19.24M | 0.0% | N/A | 1.261% | |
| 11/6/2020 | Principal Financial Group Inc. | 200,800 | $7.13M | 0.0% | N/A | 0.467% | |
| 11/4/2020 | Jennison Associates LLC | 150,000 | $5.33M | 0.0% | N/A | 0.349% | |
Data available starting January 2016
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores p53 function. It is also developing p53 R273H mutation and other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.
Read More on PMV Pharmaceuticals
Today's Range
Now: $35.00
52 Week Range
Now: $35.00
Volume
112,358 shs
Average Volume
154,050 shs
Market Capitalization
$1.57 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of PMV Pharmaceuticals?
PMV Pharmaceuticals' top insider investors include:
- Winston Kung (CFO)
- Leila Alland (Insider)
- Ra Capital Management, LP (Major Shareholder)
- Thilo Schroeder (Director)
Who are the major institutional investors of PMV Pharmaceuticals?
PMV Pharmaceuticals' top institutional shareholders include:
- Interwest Venture Management Co. — 12.21%
- BlackRock Inc. — 3.17%
- Personal CFO Solutions LLC — 1.91%
- Victory Capital Management Inc. — 1.78%
- Alliancebernstein L.P. — 0.02%
- Hershey Trust Co. — 0.02%
Which major investors are selling PMV Pharmaceuticals stock?
Within the previous quarter, PMVP stock was sold by these institutional investors:
- Interwest Venture Management Co.
Within the last year, company insiders that have sold PMV Pharmaceuticals company stock include:
- Winston Kung (CFO)
- Leila Alland (Insider)
- Ra Capital Management, LP (Major Shareholder)
Which major investors are buying PMV Pharmaceuticals stock?
In the previous quarter, PMVP stock was purchased by institutional investors including:
- Personal CFO Solutions LLC
- Victory Capital Management Inc.
- BlackRock Inc.
- Hershey Trust Co.
- Hamilton Lane Advisors LLC
- Alliancebernstein L.P.
